Ana Milinkovic

3.6k total citations
70 papers, 2.3k citations indexed

About

Ana Milinkovic is a scholar working on Infectious Diseases, Emergency Medicine and Virology. According to data from OpenAlex, Ana Milinkovic has authored 70 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Infectious Diseases, 41 papers in Emergency Medicine and 34 papers in Virology. Recurrent topics in Ana Milinkovic's work include HIV-related health complications and treatments (41 papers), HIV/AIDS drug development and treatment (37 papers) and HIV Research and Treatment (34 papers). Ana Milinkovic is often cited by papers focused on HIV-related health complications and treatments (41 papers), HIV/AIDS drug development and treatment (37 papers) and HIV Research and Treatment (34 papers). Ana Milinkovic collaborates with scholars based in Spain, United Kingdom and Italy. Ana Milinkovic's co-authors include Estebán Martínez, Josep Mallolas, José Luís Blanco, Elisa de Lazzari, María Larrousse, Agathe León, José M. Gatell, Montserrat Loncà, Montserrat Laguno and Óscar Miró and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ana Milinkovic

65 papers receiving 2.2k citations

Peers

Ana Milinkovic
José Luís Blanco Spain
Laura Smeaton United States
Ellen Tedaldi United States
Eva Wolf Germany
Montserrat Laguno Spain
Karam Mounzer United States
Markus Bickel Germany
Catherine Godfrey United States
Franco Maggiolo Italy
Vincenzo Colangeli Italy
José Luís Blanco Spain
Ana Milinkovic
Citations per year, relative to Ana Milinkovic Ana Milinkovic (= 1×) peers José Luís Blanco

Countries citing papers authored by Ana Milinkovic

Since Specialization
Citations

This map shows the geographic impact of Ana Milinkovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Milinkovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Milinkovic more than expected).

Fields of papers citing papers by Ana Milinkovic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Milinkovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Milinkovic. The network helps show where Ana Milinkovic may publish in the future.

Co-authorship network of co-authors of Ana Milinkovic

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Milinkovic. A scholar is included among the top collaborators of Ana Milinkovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Milinkovic. Ana Milinkovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Milinkovic, Ana, Borja Mora‐Peris, Dana Ogaz, et al.. (2025). HIV seroconversions and genotypic viral resistance profiles in the PrEP impact trial. HIV Medicine. 26(8). 1300–1303.
2.
Dirajlal‐Fargo, Sahera, Jennifer Jao, Jorge Pinto, et al.. (2025). Cardiometabolic Health Burden in Pediatric HIV: Unmet Need in the Contemporary Antiretroviral Therapy Era. Cureus. 17(6). e85329–e85329. 1 indexed citations
3.
Batterham, Rachel L., Roger Bedimo, Ricardo Sobhie Diaz, et al.. (2024). Cardiometabolic health in people with HIV: expert consensus review. Journal of Antimicrobial Chemotherapy. 79(6). 1218–1233. 7 indexed citations
4.
5.
Gilleece, Yvonne, et al.. (2023). Real world utilisation of doravirine among people living with human immunodeficiency virus in England (DRIVE-REAL). International Journal of STD & AIDS. 35(3). 206–216. 1 indexed citations
6.
Bracchi, Margherita, Nicole Pagani, Alessia Dalla Pria, et al.. (2021). A phase IV, open-label three-arm study investigating the impact of a combination of tenofovir disoproxil fumarate/emtricitabine with raltegravir or dolutegravir or elvitegravir/cobicistat on renal function in HIV-1 antiretroviral naïve patients.. PubMed. 22(5). 128–139.
7.
Francesco, Davide De, Alan Winston, Jonathan Underwood, et al.. (2019). Cognitive function, depressive symptoms and syphilis in HIV-positive and HIV-negative individuals. International Journal of STD & AIDS. 30(5). 440–446. 9 indexed citations
8.
Milinkovic, Ana, F. Berger, Alejandro Arenas‐Pinto, & Stefan Mauss. (2019). Reversible effect on lipids by switching from tenofovir disoproxil fumarate to tenofovir alafenamide and back. AIDS. 33(15). 2387–2391. 41 indexed citations
9.
10.
Arenas‐Pinto, Alejandro, et al.. (2015). Systemic inflammation and residual viraemia in HIV-positive adults on protease inhibitor monotherapy: a cross-sectional study. BMC Infectious Diseases. 15(1). 138–138. 14 indexed citations
11.
Laguno, Montserrat, María Larrousse, José Luís Blanco, et al.. (2008). Prevalence and Clinical Relevance of Occult Hepatitis B in the Fibrosis Progression and Antiviral Response to INF Therapy in HIV–HCV-Coinfected Patients. AIDS Research and Human Retroviruses. 24(4). 547–553. 12 indexed citations
12.
León, Agathe, Estebán Martínez, Ana Milinkovic, et al.. (2008). Influence of repeated cycles of structured therapy interruption on the rate of recovery of CD4+ T cells after highly active antiretroviral therapy resumption. Journal of Antimicrobial Chemotherapy. 63(1). 184–188. 8 indexed citations
13.
Larrousse, María, Montserrat Laguno, Marta Segarra, et al.. (2007). Noninvasive Diagnosis of Hepatic Fibrosis in HIV/HCV-Coinfected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 46(3). 304–311. 29 indexed citations
14.
Hill, Andrew, Kiat Ruxrungtham, Mattana Hanvanich, et al.. (2007). Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment. Expert Opinion on Pharmacotherapy. 8(5). 679–688. 60 indexed citations
15.
Laguno, Montserrat, María Larrousse, Javier Murillas, et al.. (2006). Predictive Value of Early Virologic Response in HIV/Hepatitis C Virus-Coinfected Patients Treated With an Interferon-Based Regimen Plus Ribavirin. JAIDS Journal of Acquired Immune Deficiency Syndromes. 44(2). 174–178. 18 indexed citations
16.
Suy, Anna, Estebán Martínez, Oriol Coll, et al.. (2005). Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. AIDS. 20(1). 59–66. 156 indexed citations
17.
Laguno, Montse, José M. Sánchez–Tapias, Javier Murillas, et al.. (2005). Avances en el diagnóstico y tratamiento de la infección por el VHC en pacientes con y sin infección por el VIH. Enfermedades Infecciosas y Microbiología Clínica. 23(1). 32–40. 8 indexed citations
18.
Milinkovic, Ana & Estebán Martínez. (2005). Current perspectives on HIV-associated lipodystrophy syndrome. Journal of Antimicrobial Chemotherapy. 56(1). 6–9. 39 indexed citations
19.
Martínez, Estebán, Ana Milinkovic, Elisa de Lazzari, et al.. (2004). Pancreatic toxic effects associated with co-administration of didanosine and tenofovir in HIV-infected adults. The Lancet. 364(9428). 65–67. 49 indexed citations
20.
Martínez, Estebán, Peré Domingo, Marı́a José Galindo, et al.. (2004). Risk of Metabolic Abnormalities in Patients Infected with HIV Receiving Antiretroviral Therapy that Contains Lopinavir‐Ritonavir. Clinical Infectious Diseases. 38(7). 1017–1023. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José Luís Blanco Breakdown of academic impact, for papers by Laura Smeaton Breakdown of academic impact, for papers by Ellen Tedaldi Breakdown of academic impact, for papers by Eva Wolf Breakdown of academic impact, for papers by Montserrat Laguno Breakdown of academic impact, for papers by Karam Mounzer Breakdown of academic impact, for papers by Markus Bickel Breakdown of academic impact, for papers by Catherine Godfrey Breakdown of academic impact, for papers by Franco Maggiolo Breakdown of academic impact, for papers by Vincenzo Colangeli
Rankless by CCL
2026